131 related articles for article (PubMed ID: 33075375)
1. Genistin attenuates cellular growth and promotes apoptotic cell death breast cancer cells through modulation of ERalpha signaling pathway.
Hwang ST; Yang MH; Baek SH; Um JY; Ahn KS
Life Sci; 2020 Dec; 263():118594. PubMed ID: 33075375
[TBL] [Abstract][Full Text] [Related]
2. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
3. Different anticancer effects of Saxifragifolin A on estrogen receptor-positive and estrogen receptor-negative breast cancer cells.
Kim KH; Kim JY; Kwak JH; Pyo S
Phytomedicine; 2015 Aug; 22(9):820-8. PubMed ID: 26220629
[TBL] [Abstract][Full Text] [Related]
4. Formononetin promotes proliferation that involves a feedback loop of microRNA-375 and estrogen receptor alpha in estrogen receptor-positive cells.
Chen J; Zhang X; Wang Y; Ye Y; Huang Z
Mol Carcinog; 2016 Mar; 55(3):312-9. PubMed ID: 25663261
[TBL] [Abstract][Full Text] [Related]
5. Annonacin induces cell cycle-dependent growth arrest and apoptosis in estrogen receptor-α-related pathways in MCF-7 cells.
Ko YM; Wu TY; Wu YC; Chang FR; Guh JY; Chuang LY
J Ethnopharmacol; 2011 Oct; 137(3):1283-90. PubMed ID: 21840388
[TBL] [Abstract][Full Text] [Related]
6. Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ERα-ΔNp63-Integrin β4 Signaling Pathway.
Ho JY; Chang FW; Huang FS; Liu JM; Liu YP; Chen SP; Liu YL; Cheng KC; Yu CP; Hsu RJ
PLoS One; 2016; 11(2):e0148301. PubMed ID: 26845172
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells.
Zhang X; Mukerji R; Samadi AK; Cohen MS
BMC Complement Altern Med; 2011 Oct; 11():84. PubMed ID: 21978374
[TBL] [Abstract][Full Text] [Related]
8. Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.
Tian J; Wang Y; Zhang X; Ren Q; Li R; Huang Y; Lu H; Chen J
J Exp Clin Cancer Res; 2017 Nov; 36(1):153. PubMed ID: 29096683
[TBL] [Abstract][Full Text] [Related]
9. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
10. Furanodienone inhibits cell proliferation and survival by suppressing ERα signaling in human breast cancer MCF-7 cells.
Li YW; Zhu GY; Shen XL; Chu JH; Yu ZL; Fong WF
J Cell Biochem; 2011 Jan; 112(1):217-24. PubMed ID: 21069738
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptors participate in silibinin-caused nuclear translocation of apoptosis-inducing factor in human breast cancer MCF-7 cells.
Liu W; Ji Y; Sun Y; Si L; Fu J; Hayashi T; Onodera S; Ikejima T
Arch Biochem Biophys; 2020 Aug; 689():108458. PubMed ID: 32524997
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
13. Dual effects of isoflavonoids from Pueraria lobata roots on estrogenic activity and anti-proliferation of MCF-7 human breast carcinoma cells.
Ahn SY; Jo MS; Lee D; Baek SE; Baek J; Yu JS; Jo J; Yun H; Kang KS; Yoo JE; Kim KH
Bioorg Chem; 2019 Mar; 83():135-144. PubMed ID: 30352359
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.
Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK
Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk of ROS/RNS and autophagy in silibinin-induced apoptosis of MCF-7 human breast cancer cells in vitro.
Zheng N; Liu L; Liu WW; Li F; Hayashi T; Tashiro SI; Onodera S; Ikejima T
Acta Pharmacol Sin; 2017 Feb; 38(2):277-289. PubMed ID: 27867187
[TBL] [Abstract][Full Text] [Related]
16. Reduced camptothecin sensitivity of estrogen receptor-positive human breast cancer cells following exposure to di(2-ethylhexyl)phthalate (DEHP) is associated with DNA methylation changes.
Chou CK; Huang HW; Yang CF; Dahms HU; Liang SS; Wang TN; Kuo PL; Hsi E; Tsai EM; Chiu CC
Environ Toxicol; 2019 Apr; 34(4):401-414. PubMed ID: 30720231
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor beta-mediated proliferative inhibition and apoptosis in human breast cancer by calycosin and formononetin.
Chen J; Zhao X; Ye Y; Wang Y; Tian J
Cell Physiol Biochem; 2013; 32(6):1790-7. PubMed ID: 24355881
[TBL] [Abstract][Full Text] [Related]
18. Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha.
Lin W; Huang J; Liao X; Yuan Z; Feng S; Xie Y; Ma W
Pharmacol Res; 2016 Sep; 111():849-858. PubMed ID: 27491559
[TBL] [Abstract][Full Text] [Related]
19. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibitory potencies and mechanisms of the type I ribosome inactivating protein marmorin on estrogen receptor (ER)-positive and ER-negative breast cancer cells.
Pan WL; Wong JH; Fang EF; Chan YS; Ye XJ; Ng TB
Biochim Biophys Acta; 2013 May; 1833(5):987-96. PubMed ID: 23274857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]